Aperio Group’s Quorum Health Corporation QHC Stock Holding History

Aperio Group’s Portfolio QHC Stock Details QHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-53	Closed	–	–	2978
2019 Q2	$0	Buy	+53	New	+$87	﹤0.01%	3061

Other funds holding QHC

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

CCM

Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aperio Group's QHC Position: Q3 2019 in Review

Aperio Group sold out of Quorum Health Corporation (QHC) in Q3 2019, closing a stake of 53 shares.

Aperio Group first reported a position in QHC in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 70 funds tracked by Wall St. Rank hold QHC as of Q3 2019.

Aperio Group reported no remaining Quorum Health Corporation position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 53 Quorum Health Corporation shares in Q3 2019.
Aperio Group first reported a position in Quorum Health Corporation in Q2 2019 and held it in 1 quarter.
Aperio Group's Quorum Health Corporation position peaked at $0 in Q2 2019.
70 funds tracked by Wall St. Rank held Quorum Health Corporation as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.